Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Six policy lessons relevant to cannabis legalization
Chelsea L. Shover, Keith Humphreys
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 698-706
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

Assessing the public health impacts of legalizing recreational cannabis use: the US experience
Wayne Hall, Michael T. Lynskey
World Psychiatry (2020) Vol. 19, Iss. 2, pp. 179-186
Open Access | Times Cited: 232
U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020
Kevin F. Boehnke, Owen Dean, Rebecca L. Haffajee, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 945-951
Open Access | Times Cited: 70
International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis
Anees Bahji, Callum Stephenson
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 17, pp. 3095-3095
Open Access | Times Cited: 87
Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA
Vivian Chiu, Janni Leung, Wayne Hall, et al.
Neuropharmacology (2021) Vol. 193, pp. 108610-108610
Closed Access | Times Cited: 68
The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review
Jakob Manthey, Britta M. Jacobsen, Tobias Hayer, et al.
International Journal of Drug Policy (2023) Vol. 116, pp. 104039-104039
Closed Access | Times Cited: 24
Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022
Kevin F. Boehnke, Rachel Sinclair, Felicia Gordon, et al.
Annals of Internal Medicine (2024) Vol. 177, Iss. 4, pp. 458-466
Closed Access | Times Cited: 10
Prenatal Cannabis Use and Maternal Pregnancy Outcomes
Kelly C. Young‐Wolff, Sara R. Adams, Stacey E. Alexeeff, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1083-1083
Open Access | Times Cited: 9
Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?
Christina M. Andrews, Wayne Hall, Keith Humphreys, et al.
Addiction (2024)
Open Access | Times Cited: 7
Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Addictive Behaviors (2023) Vol. 140, pp. 107617-107617
Open Access | Times Cited: 19
How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?
Wayne Hall, Janni Leung, Beatriz H. Carlini
Addiction (2023) Vol. 118, Iss. 6, pp. 998-1003
Open Access | Times Cited: 16
Trends and correlates of cannabis use in Canada: a repeated cross-sectional analysis of national surveys from 2004 to 2017
Dana E. Lowry, Daniel J. Corsi
CMAJ Open (2020) Vol. 8, Iss. 3, pp. E487-E495
Open Access | Times Cited: 43
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations
Benedikt Fischer, Dimitri Daldegan‐Bueno, Joseph M. Boden
Drug and Alcohol Review (2020) Vol. 39, Iss. 5, pp. 555-567
Open Access | Times Cited: 35
Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws
Deborah S. Hasin, Jacob T. Borodovsky, Dvora Shmulewitz, et al.
Drug and Alcohol Dependence (2021) Vol. 229, pp. 109159-109159
Open Access | Times Cited: 31
Social media discourse and internet search queries on cannabis as a medicine: A systematic scoping review
Christine Mary Hallinan, Sedigh Khademi, Mike Conway, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0269143-e0269143
Open Access | Times Cited: 12
Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis
Christine Mary Hallinan, Jane Gunn, Yvonne Bonomo
BMJ Open (2021) Vol. 11, Iss. 10, pp. e054044-e054044
Open Access | Times Cited: 25
The medical cannabis regulatory framework in Canada: A narrative review
Jeremy Y. Ng, Pargol Homayouni, Sana Usman, et al.
European Journal of Integrative Medicine (2022) Vol. 50, pp. 102104-102104
Closed Access | Times Cited: 17
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Krzysztof Laudański, Justin Wain
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 558-558
Open Access | Times Cited: 14
From drug prohibition to regulation: a public health imperative
Kasia Malinowska-Sempruch, Diederik Lohman
The Lancet (2022) Vol. 400, Iss. 10353, pp. 645-646
Open Access | Times Cited: 14
Assessing New Zealand’s Cannabis Legalization and Control Bill: prospects and challenges
Chris Wilkins, Marta Rychert
Addiction (2020) Vol. 116, Iss. 2, pp. 222-230
Closed Access | Times Cited: 22
Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review
Janni Leung, Daniel Stjepanović, Danielle Dawson, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 19
Primary crime-related outcome indicators associated with recreational cannabis legalization: a comprehensive literature and data review
Benedikt Fischer, Tessa Robinson, Hans‐Jörg Albrecht
Crime Law and Social Change (2024) Vol. 82, Iss. 3, pp. 685-715
Closed Access | Times Cited: 2
Prevalence of cannabidiol use and correlates in U.S. adults
Namkee G. Choi, C. Nathan Marti, Bryan Y. Choi
Drug and Alcohol Dependence Reports (2024) Vol. 13, pp. 100289-100289
Open Access | Times Cited: 2
Association of State Policies Allowing Medical Cannabis for Opioid Use Disorder With Dispensary Marketing for This Indication
Chelsea L. Shover, Noel Vest, Derek Chen, et al.
JAMA Network Open (2020) Vol. 3, Iss. 7, pp. e2010001-e2010001
Open Access | Times Cited: 18
Assessment tools for problematic opioid use in palliative care: A scoping review
Jenny Lau, Paolo Mazzotta, Rouhi Fazelzad, et al.
Palliative Medicine (2021) Vol. 35, Iss. 7, pp. 1295-1322
Open Access | Times Cited: 15
Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010–2021
Thomas Rotering, Dorie E. Apollonio
International Journal of Drug Policy (2022) Vol. 102, pp. 103585-103585
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top